Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C18H32O15 |
| Molecular Weight | 488.4377 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 14 / 14 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
C[C@@H]1O[C@@H](O[C@@H](C=O)[C@@H](O[C@H]2O[C@H](CO)[C@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@H](O)CO)[C@@H](O)[C@H](O)[C@@H]1O
InChI
InChIKey=OZIOWHWTZWIMCZ-MPUPURDASA-N
InChI=1S/C18H32O15/c1-5-9(23)12(26)14(28)17(30-5)32-8(4-21)16(10(24)6(22)2-19)33-18-15(29)13(27)11(25)7(3-20)31-18/h4-20,22-29H,2-3H2,1H3/t5-,6+,7+,8-,9+,10-,11-,12+,13-,14-,15+,16+,17-,18+/m0/s1
| Molecular Formula | C18H32O15 |
| Molecular Weight | 488.4377 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 14 / 14 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
B-Trisaccharide belongs to the class of organic compounds known as fatty acyl glycosides of mono- and disaccharides. B-Trisaccharide in blood group B is excreted when an individual is given Galactose. The B-trisaccharide was the only oligosaccharide detected in plasma after galactose administration to a blood-group-B secretor individual. The structure of the branched blood group B trisaccharide alone has been studied both by X-ray crystallography and by NMR.
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 21:40:07 GMT 2025
by
admin
on
Mon Mar 31 21:40:07 GMT 2025
|
| Record UNII |
2P888H42QS
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
FDA ORPHAN DRUG |
27988
Created by
admin on Mon Mar 31 21:40:07 GMT 2025 , Edited by admin on Mon Mar 31 21:40:07 GMT 2025
|
||
|
FDA ORPHAN DRUG |
18887
Created by
admin on Mon Mar 31 21:40:07 GMT 2025 , Edited by admin on Mon Mar 31 21:40:07 GMT 2025
|
||
|
FDA ORPHAN DRUG |
18086
Created by
admin on Mon Mar 31 21:40:07 GMT 2025 , Edited by admin on Mon Mar 31 21:40:07 GMT 2025
|
||
|
FDA ORPHAN DRUG |
20287
Created by
admin on Mon Mar 31 21:40:07 GMT 2025 , Edited by admin on Mon Mar 31 21:40:07 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
49777-14-2
Created by
admin on Mon Mar 31 21:40:07 GMT 2025 , Edited by admin on Mon Mar 31 21:40:07 GMT 2025
|
PRIMARY | |||
|
2P888H42QS
Created by
admin on Mon Mar 31 21:40:07 GMT 2025 , Edited by admin on Mon Mar 31 21:40:07 GMT 2025
|
PRIMARY | |||
|
61010
Created by
admin on Mon Mar 31 21:40:07 GMT 2025 , Edited by admin on Mon Mar 31 21:40:07 GMT 2025
|
PRIMARY | |||
|
DTXSID001045087
Created by
admin on Mon Mar 31 21:40:07 GMT 2025 , Edited by admin on Mon Mar 31 21:40:07 GMT 2025
|
PRIMARY | |||
|
54177368
Created by
admin on Mon Mar 31 21:40:07 GMT 2025 , Edited by admin on Mon Mar 31 21:40:07 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |